Skip to content

Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis

Prepared Meals to Prime and Perpetuate Reduced Dietary Sodium Intake in Hemodialysis

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03990311
Acronym
PEPPERDISH
Enrollment
40
Registered
2019-06-18
Start date
2019-06-05
Completion date
2021-12-31
Last updated
2023-01-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Fluid Overload in Dialysis Patients, Hypertension in Dialysis Patients

Brief summary

This is a randomized clinical trial in which maintenance hemodialysis patients will be provided with salt restricted 'dialysis friendly' meals and compared to a control arm receiving usual care.

Detailed description

Patients randomized to the intervention arm will receive 2 months of meals plus dietary counseling. Counseling will continue for an additional 3 months while the control arm will have 5 months of usual care followed by 2 months of meal provision. Effects on interdialytic weight gain, achievement of target dry weight, intradialytic hypotension episodes, blood pressure, and a volume assessment using lung U/S to assess lung water will be measured. Salt sensitivity will be tested throughout the study. Self reported questionnaires about the burden of adhering to the low salt diet and the level of adherence with it will be completed at baseline and throughout the study. The investigator hypothesizes that the prepared meals with prime patients behavior and may alter salt taste perception and that these effects will be sustained after the prepared meals have stopped.

Interventions

OTHERSodium Restricted Meals

2 meals prepared with 2 g /day sodium restriction and adhering to dietary recommendations for a hemodialysis patients (phosphate and potassium restricted/ high protein content) 2 meals per day for first month of meal provision period followed by 1 meal per month in the second meal of meal provision period

OTHERControl

Usual Care

Sponsors

Tufts Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SEQUENTIAL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

BP, weight, IDH (as defined by an intra-or post dialysis BP \<90 mmHg) will be recorded per usual clinical care by the dialysis unit staff. Patients will be blinded to the salinity of the salt solutions used to test taste perception and preference.

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Age \>18 2. Treated with outpatient hemodialysis for \>60 days 3. Mean IDWG over the past 30 days \>2 kg 4. Speaks and understands English or Chinese 5. Patient has a freezer at home with space to store at least 7 prepared meals 6. Cognitively intact (able to provide informed consent and answer questionnaires)

Exclusion criteria

\-

Design outcomes

Primary

MeasureTime frameDescription
Change in Interdialytic Weight Gain throughout Length of StudyEvery two weeks starting through 5months (intervention arm)/ 7 months (control arm)A standard measurement taken for HD patients at each dialysis session to see weight gained between sessions

Secondary

MeasureTime frameDescription
Rate of Intradialytic Hypotension Episodes throughout Length of StudyEvery two weeks starting at baseline and through 5months (Control Arm)/ 7 months (intervention arm)Intradialytic Systolic BP \<90 mm Hg

Other

MeasureTime frameDescription
Salt Taste Preferencethrough 5months (intervention arm)/ 7 months (control arm)Testing salty solution taste preference via sip, swish, and spit and, in the opinion of the participant, selecting which solution tasted better.
Pre-dialysis Blood Pressurethrough 5months (intervention arm)/ 7 months (control arm)BP measurement prior to dialysis, taken for HD patients at each session
Rate of Achievement of Estimated Dry Weightthrough 5months (intervention arm)/ 7 months (control arm)Post-weight not greater than EDW by 0.5 kg
Fluid Overloadthrough 5months (intervention arm)/ 7 months (control arm)As defined by lung U/S at the end of the dialysis treatment
Salt Taste Perceptionthrough 5months (intervention arm)/ 7 months (control arm)Testing salty solution taste perception via sip, swish, and spit and rating saltiness on a general Labeled Magnitude Scale ranging from Barely Detectable to Strongest Imaginable.

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026